Evaluation of gentamicin pharmacokinetics and dosing protocols in 195 neonates

American Journal of Health-System Pharmacy

Volumn 55, Issue 21, 1998, Pages 2280-2288

  Murphy, John E ^a   Austin, Mauricio L ^b   Frye, Reginald F ^c  

^a UNIVERSITY OF ARIZONA   (United States)

^b Safeway Inc   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Age; Aminoglycosides; Blood levels; Dosage schedules; Drugs, body distribution; Excretion; Gentamicin; Half life; Pediatrics; Pharmacokinetics; Protocols; Weight

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; GENTAMICIN;

ANTIBIOTIC THERAPY; APGAR SCORE; ARTICLE; COST MINIMIZATION ANALYSIS; DATA ANALYSIS; DOSE RESPONSE; DRUG DISTRIBUTION; DRUG EFFECT; DRUG EXCRETION; DRUG HALF LIFE; FEMALE; GESTATIONAL AGE; GRAM NEGATIVE INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL;

EID: 0032213003     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/55.21.2280     Document Type: Article

References (15)

1. Lopez-Samblas AM, Torres CL, Wang H et al. Effectiveness of a gentamicin dosing protocol based on postconceptional age: comparison to published neonatal guidelines. Ann Pharmacother. 1992; 26:534-8.
2. Izquierdo M, Lanao JM, Cervero L et al. Population pharmacokinetics of gentamicin in premature infants. Ther Drug Monit. 1992; 14:177-83.
3. Rodvold KA, Gentry CA, Plank GS et al. Prediction of gentamicin concentrations in neonates and infants using a Bayesian pharmacokinetics model. Dev Pharmacol Ther. 1993; 20:211-9.
4. Faura CC, Feret MA, Horga JF. Monitoring serum levels of gentamicin to develop a new regimen for gentamicin dosage in newborns. Ther Drug Monit. 1991; 13:268-76.
5. Semchuk W, Borgmann J, Bowman L. Determination of a gentamicin loading dose in neonates and infants. Ther Drug Monit. 1993; 15:47-51.
6. Brion LP, Fleischman AR, Schwartz GJ. Gentamicin interval in newborn infants as determined by renal function and postconceptional age. Pediatr Nephrol. 1991; 5:675-8.
7. Pons G, d'Athis P, Rey E et al. Gentamicin monitoring in neonates. Ther Drug Monit. 1988; 10:421-7.
8. Nakae S, Yamada M, Ito T et al. Gentamicin dosing and pharmacokinetics in low birth weight infants. Tohoku J Exp Med. 1988; 155:213-23.
9. Angeles de Cos M, Gomez-Ullate J, Gomez F et al. Time course of trough serum gentamicin concentrations in pre-term and term neonates. Clin Pharmacokinet. 1992; 23:391-401.
10. Murphy JE, Carter JT. Gentamicin in newborns: evaluating dosing and monitoring in a community hospital and development of dosing guidelines. Hosp Pharm. 1996; 31:1283-9.
11. Murphy JE, ed. Clinical pharmacokinetics pocket reference. Bethesda, MD: American Society of Hospital Pharmacists; 1993.
12. Smith RV, Stewart JT. Textbook of biopharmaceutic analysis. Philadelphia: Lea & Febiger; 1981:84-5.
13. Murphy JE, Winter ME. Clinical pharmacokinetic pearls: using bolus vs infusion equations. Pharmacotherapy. 1996; 16:698-700.
14. Pagano M, Gauvreau K. Principles of biostatistics. Belmont, CA: Wadsworth; 1993.
15. Nicolau DP, Freeman CD, Belliveau PP et al. Experience with a once-daily aminoglycoside program administered to 2,184 adult patients. Antimicrob Agents Chemother. 1995; 39:650-5.